A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/ Influsplit SSW [influenza virus vaccine] 2008/2009 in People Aged 18 Years or Above
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2018
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline
- 04 Aug 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
- 02 Aug 2008 New trial record.